Delta Global Management LP decreased its holdings in The Clorox Company (NYSE:CLX – Free Report) by 73.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,354 shares of the company’s stock after selling 14,917 shares during the period. Delta Global Management LP’s holdings in Clorox were worth $540,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of CLX. Vermillion & White Wealth Management Group LLC bought a new position in Clorox in the 3rd quarter worth about $25,000. Darwin Wealth Management LLC purchased a new stake in shares of Clorox in the 2nd quarter worth $29,000. Vision Financial Markets LLC lifted its holdings in shares of Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after buying an additional 200 shares during the period. Ameriflex Group Inc. lifted its holdings in shares of Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock worth $36,000 after buying an additional 273 shares during the period. Finally, Elevated Capital Advisors LLC purchased a new stake in shares of Clorox in the 4th quarter worth $43,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently commented on CLX shares. Barclays reduced their price target on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a report on Friday, May 1st. The Goldman Sachs Group restated a “sell” rating and issued a $83.00 price target on shares of Clorox in a report on Friday, May 1st. JPMorgan Chase & Co. reduced their price target on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, May 1st. Evercore restated an “underperform” rating and issued a $110.00 price target on shares of Clorox in a report on Friday, May 1st. Finally, BNP Paribas Exane reduced their price target on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating for the company in a report on Tuesday, May 12th. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Clorox has a consensus rating of “Reduce” and a consensus target price of $103.40.
Insider Activity at Clorox
In related news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. This trade represents a 38.46% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.63% of the stock is owned by insiders.
Clorox Stock Up 1.6%
Shares of Clorox stock opened at $97.52 on Wednesday. The firm’s 50 day moving average price is $96.26 and its 200-day moving average price is $105.05. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The company has a market cap of $11.79 billion, a P/E ratio of 15.83, a PEG ratio of 0.50 and a beta of 0.56.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business’s quarterly revenue was up .1% on a year-over-year basis. During the same quarter last year, the firm earned $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, sell-side analysts predict that The Clorox Company will post 5.61 EPS for the current fiscal year.
Clorox Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Featured Stories
- Five stocks we like better than Clorox
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
